
RehnaKrishnan
@krishnanrehna
ID: 1024552054931345409
01-08-2018 07:06:59
48 Tweet
20 Followers
62 Following




Results of a phase I/II clinical trial led by University Health Network Drs. gelareh-zadeh and Farshad Nassiri reveal that a novel combination therapy for #glioblastoma is well-tolerated and prolongs patient survival > uhnresearch.ca/news/promising… nature.com/articles/s4159… Krembil Brain Institute Princess Margaret Cancer Centre Research


Recent study led by Dr. Razq Hakem University Health Network uncovers a new class of therapeutic targets for breast and ovarian cancers associated with BRCA1 mutations. Read here > uhnresearch.ca/news/finding-d…; doi.org/10.1093/nar/gk… Princess Margaret Cancer Centre


Congratulations to Shane Harding for being the winner of the Mona Gauthier Award, presented to a scientist who displays excellence and commitment to research.


Had a productive meeting with Pfizer Inc. executives in New York. Discussed setting up a branch of their research centre in #Kerala, and utilizing our state's expertise in biotech, bioinformatics, statistics, and applied math. Excited for the potential partnership ahead!





Excited to share our work “Insulin Receptor Loss Impairs Mammary Tumorigenesis in Mice“. Led by Lauren Podmore and Yekaterina Poloz, our study reveals a major function of INSR in breast/mammary tumour initiation, likely independent of its kinase activity.cell.com/cell-reports/f…




📢Permanent position open📢 We offer a permanent contract with a competitive salary for a Senior Research Scientist with high motivation and proven experience in functional genomics. Contact: [email protected] cnio.es/empleo/researc… Come join us CNIO Stop Cancer

New preprint from Karim Mekhail lab! 😀 The first nucleolar RNA Pol II interactome helps uncover roles for RNA Pol I, TBPL1, and PAF1 at intergenic rDNA in ribosome biogenesis. biorxiv.org/cgi/content/sh…


Read the latest #research on #Nucleolar RNA Polymerase II, #ribosome biogenesis, and #protein synthesis (in final form). Congrats to first-author Negin Khosraviani and our amazing coauthors and collaborators. doi.org/10.1038/s41467…

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment academic.oup.com/narcancer/arti… IDIBELL IDIBGI Institut d'Investigació Biomèdica de Girona Institut Català d'Oncologia By fantastic Roderic Espin! And thanks to many - Aytes & Vinyals teams! IDIBELL IDIBGI Institut d'Investigació Biomèdica de Girona Institut Català d'Oncologia Centres CERCA
